Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 5Myeloproliferative Disorders 3Advanced Solid Tumour 3Small Cell Lung Carcinoma 2Recurrence 2Leukemia, Myelomonocytic, Chronic 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuroma 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Multiple Myeloma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Idiopathic Pulmonary Fibrosis 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Blast Crisis 1Anxiety Disorders 1Amyotrophic Lateral Sclerosis 1Advanced Malignant Solid Tumors 1Advanced Lung Cancer 1Advanced Breast Cancer 1

Interventions

Gemcitabine 6Mitomycin 4erdafitinib 3viscum album peptide 1pirarubicin 1hydroxycamptothecinum 1durvalumab 1Watchful Waiting 1Transurethral Resection of Bladder 1Magnetic Resonance Spectroscopy 1Injections 1Epirubicin 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Injections × 30 days × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡